Quarterly report pursuant to Section 13 or 15(d)

Cash Equivalents and Marketable Securities

v3.21.1
Cash Equivalents and Marketable Securities
3 Months Ended
Mar. 31, 2021
Cash And Cash Equivalents [Abstract]  
Cash Equivalents and Marketable Securities

4. Cash Equivalents and Marketable Securities

Cash equivalents and marketable securities consisted of the following:

 

 

 

March 31, 2021

 

 

 

Amortized

Cost Basis

 

 

Unrealized

Gains

 

 

Unrealized

(Losses)

 

 

Fair

Value

 

 

 

(in thousands)

 

Money market funds

 

$

53,776

 

 

$

 

 

$

 

 

$

53,776

 

Commercial paper

 

 

64,344

 

 

 

 

 

 

 

 

 

64,344

 

Corporate debt securities

 

 

64,708

 

 

 

14

 

 

 

(44

)

 

 

64,678

 

Asset-based securities

 

 

36,881

 

 

 

18

 

 

 

(10

)

 

 

36,889

 

U.S. government securities

 

 

59,832

 

 

 

33

 

 

 

 

 

 

59,865

 

Supranational debt securities

 

 

13,304

 

 

 

 

 

 

(10

)

 

 

13,294

 

Total

 

 

292,845

 

 

 

65

 

 

 

(64

)

 

 

292,846

 

Less amounts classified as cash equivalents

 

 

(53,776

)

 

 

 

 

 

 

 

 

(53,776

)

Total marketable securities

 

$

239,069

 

 

$

65

 

 

$

(64

)

 

$

239,070

 

 

 

 

December 31, 2020

 

 

 

Amortized

Cost Basis

 

 

Unrealized

Gains

 

 

Unrealized

(Losses)

 

 

Fair

Value

 

 

 

(in thousands)

 

Money market funds

 

$

204,632

 

 

$

 

 

$

 

 

$

204,632

 

Commercial paper

 

 

42,208

 

 

 

 

 

 

 

 

 

42,208

 

Corporate debt securities

 

 

25,669

 

 

 

48

 

 

 

(1

)

 

 

25,716

 

Asset-based securities

 

 

12,593

 

 

 

39

 

 

 

 

 

 

12,632

 

U.S. government securities

 

 

39,743

 

 

 

44

 

 

 

(2.00

)

 

 

39,785

 

Total

 

 

324,845

 

 

 

131

 

 

 

(3

)

 

 

324,973

 

Less amounts classified as cash equivalents

 

 

(204,632

)

 

 

 

 

 

 

 

 

(204,632

)

Total marketable securities

 

$

120,213

 

 

$

131

 

 

$

(3

)

 

$

120,341

 

 

As of March 31, 2021 and December 31, 2020, $74.6 million and zero, respectively, of marketable securities had maturities of more than one year and are classified as long-term assets.

There were $84.6 million and $14.7 million of investments in an unrealized loss position of $64,000 and $3,000 as of March 31, 2021 and December 31, 2020, respectively. During the three months ended March 31, 2021 and 2020, the Company did not record any other-than-temporary impairment charges on its available-for-sale securities. Based upon the Company’s impairment review, the Company determined that the unrealized losses were not attributed to credit risk but were primarily associated with changes in interest rates. Based on the scheduled maturities of the investments, the Company was more likely than not to hold these investments for a period of time sufficient for a recovery of the Company’s cost basis.  As such, the Company concluded that the unrealized losses in the investment securities were not other-than-temporary.